If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Toshiyuki Sasaguri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Glycogen Synthase Kinase 3 Medicine & Life Sciences
Smooth Muscle Myocytes Medicine & Life Sciences
Vascular Smooth Muscle Medicine & Life Sciences
Celecoxib Medicine & Life Sciences
Catenins Medicine & Life Sciences
Wnt Signaling Pathway Medicine & Life Sciences
prostaglandin R2 D-isomerase Medicine & Life Sciences
Cells Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation

Morishige, S., Takahashi-Yanaga, F., Ishikane, S., arioka, M., Igawa, K., Kuroo, A., Tomooka, K., Shiose, A. & Sasaguri, T., Oct 1 2019, In : Biochemical Pharmacology. 168, p. 82-90 9 p.

Research output: Contribution to journalArticle

Glycogen Synthase Kinase 3
Open Access
Genetic Polymorphisms
Healthy Volunteers
Heart Rate
Blood Pressure
2 Citations (Scopus)

Cardiotonic actions of quercetin and its metabolite tamarixetin through a digitalis-like enhancement of Ca2+ transients

Hayamizu, K., Morimoto, S., Nonaka, M., Hoka, S. & Sasaguri, T., Jan 1 2018, In : Archives of Biochemistry and Biophysics. 637, p. 40-47 8 p.

Research output: Contribution to journalArticle

Cardiotonic Agents

Survey on centralization of research ethics review for multicenter clinical trials in Japan

Inano, A., Uchida, E., Inoue, Y., Kusuoka, H., Tashiro, S., Hasegawa, J., Morishita, N. & Sasaguri, T., Jan 1 2018, In : Japanese Journal of Clinical Pharmacology and Therapeutics. 49, 4, p. 159-167 9 p.

Research output: Contribution to journalReview article

Research Ethics
Multicenter Studies
Clinical Trials
7 Citations (Scopus)

2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation

Fujita, A., Takahashi-Yanaga, F., Morimoto, S., Yoshihara, T., arioka, M., Igawa, K., Tomooka, K., Hoka, S. & Sasaguri, T., Feb 1 2017, In : Hypertension Research. 40, 2, p. 130-139 10 p.

Research output: Contribution to journalArticle

Glycogen Synthase Kinase 3
Ventricular Remodeling
Heart Failure